Jgp Global Gestao De Recursos Ltda. Biocryst Pharmaceuticals Inc Transaction History

Jgp Global Gestao De Recursos Ltda.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$4.89 - $7.65 $1,051 - $1,644	215 Added 2.02%	10,865 $55,000
Q4 2023 Jan 19, 2024	BUY	$4.98 - $6.77 $53,037 - $72,100	10,650 New	10,650 $63,000
Q2 2019 Jul 19, 2019	SELL	$2.91 - $9.15 $74,909 - $235,539	-25,742 Closed	0 $0
Q1 2019 Apr 24, 2019	BUY	$7.38 - $9.72 $14,892 - $19,614	2,018 Added 8.51%	25,742 $210,000
Q4 2018 Jan 23, 2019	SELL	$6.51 - $9.6 $17,713 - $26,121	-2,721 Reduced 10.29%	23,724 $191,000
Q3 2018 Oct 25, 2018	BUY	$5.52 - $7.99 $145,976 - $211,295	26,445 New	26,445 $202,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.